Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia

黑质和基底神经节的药理学和生理学

基本信息

项目摘要

Current focus in the NPS is on mechanisms underlying the ability of dopamine-containing neurons to affect information processing in the basal ganglia and associated areas. The Sections neurophysiological studies in several different rat preparations - locally anaesthetized, immobilized and artificially respired rats, freely moving rats and systemically anesthetized rats - have provided evidence that normal levels of dopamine receptor stimulation act to prevent emergence of inappropriately synchronized and oscillatory neuronal firing activity in basal ganglia networks, while significant increases and decreases in dopamine receptor stimulation enhance the expression of these dysfunctional patterns. In the past year, we have been exploring the specifics of dysfunctional alterations in basal ganglia output in animal models of Parkinsons disease and the effects of these alterations on sites receiving basal ganglia input, such as the thalamus and peduncular pontine nucleus (PPN). We have also initiated studies to explore the consequences of deep brain stimulation (DBS) of the peduncular pontine nucleus(PPN) and subthalamic nucleus (STN) on motor cortex activity. In addition, through collaborations with researchers working in the Mouse Imaging Facility (MIF) at NIH, we have investigated the neurophysiological correlates of functional magnetic resonance imaging (fMRI) changes in cortex in animal models of stroke and sensory denervation. 1) Section Researchers in previous years have used a rodent model of Parkinsons disease, the urethane-anesthetized rat with unilateral lesion of midbrain dopamine neurons, to investigate how dopamine cell death brings about alterations in neuronal firing patterns in basal ganglia output. Our studies have strongly supported the hypothesis that loss of striatal dopamine enhances transmission of cortical firing patterns to downstream sites via the striatal-pallidal pathway, contributing to the emergence of dysfunctional oscillatory activity in the basal ganglia output nuclei as well as in downstream sites such as the PPN. Further studies in the anesthetized rat model in FY 2009 have been directed at determining whether synchronized and oscillatory activity in basal ganglia output affects activity in thalamocortical loops. a) In contrast to the changes observed in the PPN firing patterns after dopamine cell lesion, Section researchers showed in FY 2009 that spike trains in the ventroanterior-ventrolateral (VAVL) nucleus and the parafascicular nucleus (PFN) of the thalamus are not affected as hypothesized by loss of dopamine. It has been predicted that changes in basal ganglia output after dopamine cell lesion should influence VAVL and PFN activity and impact cortical function. Results do not support the view that robust increases in oscillatory activity in basal ganglia output following dopamine loss drive changes in oscillatory activity in either VAVL or PFN thalamic nuclei. Studies are underway to further investigate the effects of basal ganglia output on activity in the ventral medial (VM) nucleus of the thalamus in normal and dopamine lesioned animals. 2) The efficacy of DBS in the STN and GPi in Parkinsons disease has focused attention on the role of dysfunctional firing patterns in the basal ganglia in this disorder. Oscillatory activity in the beta frequency range (8-35 Hz) is of special interest as LFP recordings in bradykinetic parkinsonian patients during DBS electrode placement show prominent activity in this frequency range, which is reduced by dopamine receptor stimulants. However, these clinical observations raise many questions difficult to address in patients, including the extent to which beta activity is differentially expressed in the intact vs. dopamine-depleted state, what drives the increase in beta, whether STN beta activity affects spike timing in basal ganglia output, how beta activity correlates with difficulties in gait, and what the functionally significant consequences of increased basal ganglia beta output are at downstream sites, such as the PPN and motor thalamus. Insight into these questions has been sought in studies in an awake behaving rat model of Parkinsons disease in FY09. a) Rats were trained to walk in a novel rotary treadmill while EMG activity in shoulder muscle and neuronal activity in basal ganglia output were recorded. After unilateral loss of dopamine, rats made progress walking counterclockwise on the rotary treadmill, but tended to freeze during clockwise walking as this required the affected side to make more demanding adjustments of gait and posture. Neurophysiological recordings support the hypothesis that loss of dopamine is associated with increased LFP activity and neuronal spiking in the low beta (12 25 Hz) frequency range in the basal ganglia output during periods when the rats are at rest and inattentive to their environment. Data further suggest that dysfunctional expression of high beta (25 40 Hz) activity in basal ganglia output is associated with alert states and is evident at a slightly higher peak frequency during impaired walking. b) The same rat model was used to study how basal ganglia output is differentially expressed in the dopamine -depleted state before and after chronic l-dopa treatment. Acute treatment with l-dopa restores walking to control levels in the circular treadmill and reduces high beta frequency to levels comparable to those in the intact hemisphere. After chronic treatment with l-dopa, rats exhibited pronounced rotational behavior associated with marked decreases in SNpr firing rate in the dopamine-depleted hemisphere and subsequently, limb dyskinesias associated with more variable changes in SNpr rate and pattern with significant coherence with limb dyskinesia activity. c) Changes in motor cortex network function in conjunction with deep brain stimulation are underway in the urethane-anesthetized rodent model of Parkinsons disease in FY 08. Section researchers are comparing the effects of STN and PPN DBS on motor cortex activity in the rodent model of Parkinsons disease to help understand the immediate and persistent effects of these therapies in the anesthetized model, with plans to extend these studies in the awake behaving rat model of Parkinsons disease. 3) Collaborative studies are on-going in FY09 to explore the neurophysiological mechanisms underlying observations of functional magnetic resonance imaging (fMRI) activation of primary somatosensory cortex associated with reorganization following sensory deafferentation and response to stroke. To date, in vivo electrophysiological recordings and juxtacellular neuronal labeling in somatosensory cortex in urethane anesthetized rats with peripheral nerve injury have shown that deafferentation is specifically accompanied by elevated responsiveness of inhibitory interneurons, a change that is reflected in the fMRI signal but not the evoked local field potential responses. In addition, preparations have begun in FY 2009 to extend correlative studies with the MIF facility to include investigation of neurophysiological changes in cortex associated with unilateral deafferentation of the whiskers, comparing results with changes observed above with peripheral nerve injury. In addition, the section is investigating changes in cortical activity associated with recovery from stroke, focusing on oscillatory activity in the ultraslow frequency range which may facilitate axon growth and rewiring associated with recovery.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JUDITH RICHMOND WALTERS其他文献

JUDITH RICHMOND WALTERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JUDITH RICHMOND WALTERS', 18)}}的其他基金

PHARMACOLOGY AND PHYSIOLOGY OF THE SUBSTANTIA NIGRA AND BASAL GANGLIA
黑质和基底神经节的药理学和生理学
  • 批准号:
    6290613
  • 财政年份:
  • 资助金额:
    $ 154.61万
  • 项目类别:
Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia
黑质和基底神经节的药理学和生理学
  • 批准号:
    8940031
  • 财政年份:
  • 资助金额:
    $ 154.61万
  • 项目类别:
Thalamo-Cortical Plasticity: Pain, Executive Function and Loss of Dopamine
丘脑皮质可塑性:疼痛、执行功能和多巴胺丧失
  • 批准号:
    9563157
  • 财政年份:
  • 资助金额:
    $ 154.61万
  • 项目类别:
Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia
黑质和基底神经节的药理学和生理学
  • 批准号:
    7594641
  • 财政年份:
  • 资助金额:
    $ 154.61万
  • 项目类别:
Pharmacology And Physiology Of The Substantia Nigra And
黑质的药理学和生理学
  • 批准号:
    7143804
  • 财政年份:
  • 资助金额:
    $ 154.61万
  • 项目类别:
Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia
黑质和基底神经节的药理学和生理学
  • 批准号:
    8149623
  • 财政年份:
  • 资助金额:
    $ 154.61万
  • 项目类别:
Thalamo-Cortical Plasticity: Sensory Denervation and Loss of Dopamine
丘脑皮质可塑性:感觉神经支配和多巴胺丧失
  • 批准号:
    8158248
  • 财政年份:
  • 资助金额:
    $ 154.61万
  • 项目类别:
Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia
黑质和基底神经节的药理学和生理学
  • 批准号:
    7735246
  • 财政年份:
  • 资助金额:
    $ 154.61万
  • 项目类别:
Thalamo-Cortical Plasticity: Sensory Denervation and Loss of Dopamine
丘脑皮质可塑性:感觉神经支配和多巴胺丧失
  • 批准号:
    8940110
  • 财政年份:
  • 资助金额:
    $ 154.61万
  • 项目类别:
Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia
黑质和基底神经节的药理学和生理学
  • 批准号:
    9358528
  • 财政年份:
  • 资助金额:
    $ 154.61万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 154.61万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 154.61万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 154.61万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 154.61万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 154.61万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 154.61万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 154.61万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 154.61万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 154.61万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 154.61万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了